Fingerprint
Dive into the research topics of 'Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis
Mototsugu Oya, Jae Young Joung, Ji Youl Lee, Mikio Sugimoto, Young Deuk Choi, Jun Hyuk Hong, Hiroji Uemura, Kazuo Nishimura, Hideyasu Tsumura, Satoru Kawakami, Yukiyoshi Hirayama, Tae Gyun Kwon, Cheol Kwak, Hiroyoshi Suzuki, Tomoko Fujita, Masahiro Nii, David McGuinness, Melanie Dujka, Christian Poehlein, Fred Saad
- Keio University
- National Cancer Center Korea
- The Catholic University of Korea
- Kagawa University
- Yonsei University
- University of Ulsan
- Yokohama City University
- Osaka International Cancer Institute
- Kitasato University
- Saitama Medical University
- Osaka Metropolitan University
- Seoul National University
- Toho University
- AstraZeneca
- Merck
- Centre Hospitalier de L'Universite de Montreal
- Northern Care Alliance NHS Group
Research output: Contribution to journal › Article › peer-review